{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:36:01Z","timestamp":1792874161974,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U10 EY021125"],"award-info":[{"award-number":["U10 EY021125"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ajo.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,6,12]],"date-time":"2016-06-12T06:55:23Z","timestamp":1465714523000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies"],"prefix":"10.1016","volume":"168","author":[{"given":"Elizabeth","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar R.","family":"Rathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manohar","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-3555","authenticated-orcid":false,"given":"Anuradha","family":"Kanakath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Thundikandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salena M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica N.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis C.","family":"Porco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2016.06.004_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.04.001","article-title":"Vogt\u2013Koyanagi\u2013Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options","author":"Silpa-archa","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajo.2016.06.004_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.preteyeres.2016.02.002","article-title":"Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment","volume":"52","author":"Du","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.ajo.2016.06.004_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2009.08.030","article-title":"Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease","volume":"117","author":"Rao","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2016.06.004_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archopht.1991.01080050096037","article-title":"Vogt-Koyanagi-Harada syndrome. clinical course, therapy, and long-term visual outcome","volume":"109","author":"Rubsamen","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2016.06.004_bib5","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1111\/aos.12127","article-title":"Prognostic factors for clinical outcomes in patients with vogt-koyanagi-harada disease treated with high-dose corticosteroids","volume":"91","author":"Abu El-Asrar","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2016.06.004_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","article-title":"Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease","volume":"142","author":"Read","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2016.06.004_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/ICU.0b013e32833eb78c","article-title":"Vogt-Koyanagi-Harada disease: diagnosis and treatments update","volume":"21","author":"Bordaberry","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2016.06.004_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00417-014-2904-z","article-title":"High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids","volume":"253","author":"Sakata","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2016.06.004_bib9","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1111\/j.1755-3768.2010.02055.x","article-title":"Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt\u2013Koyanagi\u2013Harada disease","volume":"89","author":"Errera","year":"2011","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2016.06.004_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ophtha.2006.07.040","article-title":"Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients","volume":"114","author":"Yang","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2016.06.004_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajo.2005.04.052","article-title":"Vogt-Koyanagi-Harada disease: clinical outcomes","volume":"140","author":"Bykhovskaya","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"2-3","key":"10.1016\/j.ajo.2016.06.004_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10792-007-9062-9","article-title":"Prognostic factors in Vogt-Koyanagi-Harada disease","volume":"27","author":"Al-Kharashi","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2016.06.004_bib13","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1111\/aos.12648","article-title":"Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease","volume":"93","author":"Urzua","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2016.06.004_bib14","first-page":"1","article-title":"Clinical outcomes of patients with Vogt-Koyanagi-Harada disease over 12 years at a tertiary center","author":"Arevalo","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.ajo.2016.06.004_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/09273941003587541","article-title":"Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic Vogt-Koyanagi-Harada disease","volume":"18","author":"Cuchacovich","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.ajo.2016.06.004_bib16","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1111\/j.1755-3768.2012.02498.x","article-title":"The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease","volume":"90","author":"Abu El-Asrar","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2016.06.004_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09273940500536766","article-title":"Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy","volume":"14","author":"Paredes","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.ajo.2016.06.004_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/09273940701624312","article-title":"The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease","volume":"15","author":"Kim","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2016.06.004_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/09273948.2012.728668","article-title":"Comparison of two different combination immunosuppressive therapies in the treatment of Vogt-Koyanagi-Harada syndrome","volume":"21","author":"Arcinue","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ajo.2016.06.004_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09273940802204519","article-title":"Azathioprine in the management of autoimmune uveitis","volume":"16","author":"Pacheco","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.ajo.2016.06.004_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/ICU.0b013e3282f03d42","article-title":"Biologics in the treatment of uveitis","volume":"18","author":"Imrie","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2016.06.004_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3928\/23258160-20140709-09","article-title":"Efficacy of adalimumab for pediatric Vogt-Koyanagi-Harada syndrome","volume":"45","author":"Jeroudi","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"4","key":"10.1016\/j.ajo.2016.06.004_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/09273948.2013.775312","article-title":"Successful use of infliximab therapy in sight-threatening corticosteroid-resistant Vogt-Koyanagi-Harada disease","volume":"21","author":"Zmuda","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.ajo.2016.06.004_bib24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ophtha.2014.04.023","article-title":"A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis","volume":"121","author":"Rathinam","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2016.06.004_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2016.06.004_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2016.06.004_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2016.06.004_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","article-title":"The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics","volume":"149","author":"Multicenter Uveitis Steroid Treatment Trial Research Group","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2016.06.004_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2016.06.004_bib30","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajo.2011.05.028","article-title":"Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography","volume":"152","author":"Sugar","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2016.06.004_bib31","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00417-011-1725-6","article-title":"Transitioning from stratus OCT to cirrus OCT: a comparison and a proposed equation to convert central subfield macular thickness measurements in healthy subjects","volume":"249","author":"Abedi","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939416302689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939416302689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:40:38Z","timestamp":1762080038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939416302689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"alternative-id":["S0002939416302689"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2016.06.004","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}